PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsclostridium infections
MeSH D003015 - clostridium infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016908:Gram-positive bacterial infections
47 Companies
13 Drugs
$
Success rate
D003015: 
Clostridium infections
41 Companies
10 Drugs
$
Success rate
D001906:Botulism
13 Companies
3 Drugs
$
Success rate
D004761:Pseudomembranous enterocolitis
90 Companies
13 Drugs
$
Success rate
D004767:Enterotoxemia
0 Companies
0 Drugs
Success rate
D005738:Gas gangrene
0 Companies
0 Drugs
Success rate
D013742:Tetanus
96 Companies
10 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SandozTigecycline Tigecycline  2015-05-27   
Merck & CoBezlotoxumab Zinplava  2016-10-21   
PfizerTigecycline Tygacil  2006-04-24 $202 M Q4/18-Q3/21 
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
40%
2/5
Phase 2
89%
8/9
Phase 3
68%
13/19
Approved: 9Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Ceftriaxone,
Lidocaine
Sanofi
Ademetionine,
Teicoplanin,
Sodium chloride,
Diluent,
Octagam,
Kcl
Merck & Co
Bezlotoxumab,
Antithrombin iii,
Sodium chloride
Pfizer
Tigecycline,
Sodium chloride
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use